CASI CASI Pharmaceuticals
- 3.1700
- +0.6050+23.59%
CASI Pharmaceuticals News
Express News | CASI Pharmaceuticals Inc Qtrly Shr Loss $0.71
Express News | CASI Pharmaceuticals Announces First Quarter 2024 Business and Financial Results
Express News | CASI Pharmaceuticals Q1 Revenue USD 3.4 Million
Express News | CASI Pharmaceuticals Q1 Cash & Investments USD 18.2 Million
CASI Pharmaceuticals 1Q Loss/Shr 71c >CASI
CASI Pharmaceuticals 1Q Loss/Shr 71c >CASI
Express News | CASI Pharmaceuticals Inc Files for Mixed Shelf of Upto $50 Mln - SEC Filing
Radiopharma Stocks Higher as Sector Welcomes the Latest M&A Deal
CASI Pharmaceuticals Discloses Material Development Relating To Its Dispute With Juventas
On April 8, 2024, CASI Pharmaceuticals, announced that, with respect to the Company's previously announced dispute with Juventas Cell Therapy Ltd., an emergency arbitrator appointed by the Hong Kong I
CASI Pharmaceuticals Gets Emergency Injunctive Relief in Dispute With Juventas Cell Therapy >CASI
CASI Pharmaceuticals Gets Emergency Injunctive Relief in Dispute With Juventas Cell Therapy >CASI
CASI Pharmaceuticals: Order Prohibits Juventas From Commercializing CNCT19 >CASI
CASI Pharmaceuticals: Order Prohibits Juventas From Commercializing CNCT19 >CASI
CASI Pharmaceuticals Wins Emergency Relief Regarding the Dispute With Juventas Cell Therapy Ltd Prohibiting Juventas From Commercializing CNCT19
On April 8, 2024, CASI Pharmaceuticals, Inc., a Cayman Islands incorporated company ("CASI" or the "Company") announced that, with respect to the Company's previously announced dispute with Juventas
Recap: CASI Pharmaceuticals Q4 Earnings
CASI Pharmaceuticals (NASDAQ:CASI) reported its Q4 earnings results on Thursday, March 28, 2024 at 07:00 AM.Here's what investors need to know about the announcement.EarningsCASI Pharmaceuticals misse
CASI Pharmaceuticals GAAP EPS of -$2.02, Revenue of $33.88M
CASI Pharmaceuticals 4Q Rev $6.9M >CASI
CASI Pharmaceuticals 4Q Rev $6.9M >CASI
AstraZeneca-Fusion Deal Reignites Radiopharma Space
12 Health Care Stocks Moving In Friday's Intraday Session
GainersPsyence Biomedical (NASDAQ:PBM) stock moved upwards by 137.8% to $3.02 during Friday's regular session. The market value of their outstanding shares is at $40.4 million. Ainos (NASDAQ:AIMD) sto
Aptevo Therapeutics, Immuron, CASI Pharmaceuticals Among Healthcare Movers
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersNKGen Biotech (NASDAQ:NKGN) stock rose 18.0% to $2.16 during Thursday's pre-market session. The company's market cap stands at $47.2 million. Nutex Health (NASDAQ:NUTX) stock increased by 15.32
BYSI, PHUN and DTSS Among Pre-market Losers
Top Midday Gainers
Datasea (DTSS) said Tuesday it expects revenue of about $86 million during the fiscal year ended June 30, compared with $7 million a year ago. Shares surged 74% as intraday trading volume shot up to m
Analysis
Price Target
No Data
